Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans

Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic

(2012) Anu Puri et al.   CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy

(2010) P Firozi et al.   GENE THERAPY

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

(2010) Mark E. Davis et al.   NATURE

miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1

(2009) L. Du et al.   MOLECULAR CANCER RESEARCH

Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung Cancer

(2008) L. Prudkin et al.   CLINICAL CANCER RESEARCH

Tumor Suppressor FUS1 Signaling Pathway

(2008) Lin Ji et al.   Journal of Thoracic Oncology